Showing results (71-80 of 566) with videos related to
Sort By:
Pageof 57
International Journal of Clinical Practice. Supplement|July 23, 2005
Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARalpha and PPARgamma agonistsP Gervois, J C Fruchart, B StaelsPathologie-Biologie|April 1, 1983
[Methods of biochemical analysis in hyperliproproteinemias]J C Fruchart, V Clavey, G VanhoutteBiochemical and Biophysical Research Communications|December 31, 1990
Diacylglycerol production induced by growth hormone in Ob1771 preadipocytes arises from phosphatidylcholine breakdownR M Catalioto, G Ailhaud, R NegrelJournal of Lipid Research|August 1, 1990
Lipoprotein lipase stored in adipocytes and muscle cells is a cryptic enzymeA Pradines-Figuères, C Vannier, G AilhaudInternational Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 6, 2004
Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applicationsG Chinetti, J-C Fruchart, B StaelsCurrent Atherosclerosis Reports|December 21, 2000
The role of fibric acids in atherosclerosisJ C Fruchart, B Staels, P DuriezBulletin De L'Academie Nationale De Medecine|July 28, 2001
[New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis]J C Fruchart, B Staels, P DuriezBiochemical Society Transactions|November 1, 2006
Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXRG Chinetti, J C Fruchart, B StaelsBritish Journal of Clinical Practice. Supplement|January 1, 1996
Lipoprotein(a) as a marker for coronary heart diseaseP Duriez, J Dallongeville, J C FruchartPharmacological Research|November 20, 2001
PPARS, metabolic disease and atherosclerosisJ C Fruchart, B Staels, P DuriezPageof 57